Documentation Index
Fetch the complete documentation index at: https://support.wepayments.com.br/llms.txt
Use this file to discover all available pages before exploring further.
Dedicated guide for merchants selling cannabidiol (CBD) products to Brazilian patients
WEpayments is specialized in supporting platforms and distributors that commercialize cannabidiol (CBD) medicinal products. We act as strategic partners in payment processing and FX operations, with a focus on transparency, compliance, and operational efficiency.
ANVISA regulatory framework
The sale of CBD medications in Brazil follows ANVISA RDC nº 660/2020 guidelines.
Patient journey requirements
| Step | Description |
|---|
| 1. Medical prescription | Issued by a qualified healthcare professional |
| 2. ANVISA authorization | Patient (or legal guardian) registers with ANVISA, attaching the prescription |
| 3. Authorized purchase | With authorization, the patient can purchase medication through your platform |
Recommended operational structure with WEpayments
Foreign company
| Requirement | Description |
|---|
| Role | Legal seller of the medication, generates charge to patient |
| Account | Must have an active cross-border account at WEpayments |
| Responsibility | Responsible for the sale and payment processing |
Brazilian company
| Requirement | Description |
|---|
| Role | Service provider representing the foreign company’s products in Brazil |
| Restriction | No corporate overlap between foreign and Brazilian company |
| Compensation | Paid by foreign company via WEpayments Payout for representation or support services |
⚠️ Critical: There must be no shared corporate structure between the foreign seller and the Brazilian representative.
Payment processing
Transaction model
| Aspect | Details |
|---|
| Model | Simultaneous exchange (eFX) – BCB Resolution nº 277/2022 |
| Currency | Charges in Brazilian reais (BRL) |
| Reporting | Payin (incoming) and Payout (outgoing) in the system |
| Release condition | Funds only released after document validation |
Payment methods
| Method | Processing |
|---|
| PIX | Works normally, funds held until document approval |
| Boleto | Works normally, funds held until document approval |
| Credit Card | Works normally, funds held until document approval |
Required documentation
For the payment to be released and correctly classified as an international CBD transaction, the following documents must be submitted by the patient via your platform:
| Document | Source | Required for release |
|---|
| Medical prescription | Patient | ✅ Yes |
| ANVISA authorization | Patient | ✅ Yes |
| Invoice | Your platform | ✅ Yes |
| Identity document | Patient or legal guardian | ✅ Yes |
Payment and release timeline
Status behavior
| Step | Status in Dashboard | Funds available? |
|---|
| Payment executed (PIX/boleto) | “Paid” | ❌ No |
| Payment executed (Credit Card) | “Credited”* | ❌ No |
| Documents submitted | ”Awaiting analysis” | ❌ No |
| Documents approved | ”Credited” | ✅ Yes |
Credit card shows “Credited” initially but funds are only effectively released after document approval.
Analysis schedule
| Aspect | Details |
|---|
| Analysis days | Business days only |
| Analysis cut-off | Until 12:00 BRT |
| Status monitoring | WEpayments Dashboard > Compliance menu |
Benefits of the eFX model for CBD
| Benefit | Description |
|---|
| Agility | Faster payment processing |
| FX exposure | Reduced exposure to currency fluctuation |
| Compliance | 100% aligned with Brazilian regulations (ANVISA + BCB) |
| Local settlement | International operation with funds maintained in Brazil |
Getting started with CBD operations
| Step | Action |
|---|
| 1. Contact WEpayments | Speak with our team to activate your account |
| 2. Configure limits | Set appropriate limits for your operation |
| 3. Integrate | Use our API or Dashboard to start processing |
| 4. Collect documents | Implement document collection in your patient flow |
| 5. Monitor compliance | Track status in the Compliance menu |
